SET 2
CAS No. 2313525-20-9
SET 2( —— )
Catalog No. M34914 CAS No. 2313525-20-9
SET 2 is an antagonist of transient receptor potential vanilloid type 2(TRPV2) with an IC50 of 0.46 μM. SET 2 shows selectivity over TRPV1, TRPV3 and TRPV4.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 50 | Get Quote |
|
| 10MG | 84 | Get Quote |
|
| 25MG | 172 | Get Quote |
|
| 50MG | 291 | Get Quote |
|
| 100MG | 415 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSET 2
-
NoteResearch use only, not for human use.
-
Brief DescriptionSET 2 is an antagonist of transient receptor potential vanilloid type 2(TRPV2) with an IC50 of 0.46 μM. SET 2 shows selectivity over TRPV1, TRPV3 and TRPV4.
-
DescriptionSET2 is a selective TRPV2 antagonist (IC50=0.46 μM). SET2 blocks the TRP channel and suppresses prostate cancer cells migration. SET2 reduces the lysophosphatidic acid (LPA, a TRPV2 activator)-induced cytoplasmic calcium increases.
-
In VitroCell Migration Assay Cell Line:PC-3M prostate cancer cells Concentration:0, 5 μM, 10 μM, and 20 μM Incubation Time:24 hr and 48 hr Result:Inhibited cell migration of PC-3M cells, without inhibiting cell viability at 48 hours.
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRP/TRPV Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2313525-20-9
-
Formula Weight402.43
-
Molecular FormulaC17H21F3N4O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (248.49 mM; Ultrasonic (<60°C)
-
SMILESCCCN(C)c1cc(nc(SCCC(=O)NCc2ccco2)n1)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chai H, et al. Structure-Based Discovery of a Subtype-Selective Inhibitor Targeting a Transient Receptor Potential Vanilloid Channel. J Med Chem. 2019 Feb 14;62(3):1373-1384. ?
molnova catalog
related products
-
AM404
AM404 is an endocannabinoid reuptake inhibitor, a TRPV(1) activator, a paracetamol metabolite, with neuroprotective and anticancer activity that blocks anandamide transport.
-
A 425619
A 425619 is a potent TRPV1 antagonistsystemic administration of the TRPV1 antagonist, A-425619, reversed the decrease in digging behavior induced by CFA injection, further confirming the role of TRPV1, expressed by knee neurons, in acute inflammatory joint pain.
-
GsMTx4
GsMTx-4, mechanosensitive and stretch-activated ion channel inhibitor.
Cart
sales@molnova.com